EXICURE, INC.

Address

8045 LAMON AVE STE 410
SKOKIE, IL, 60077-5318

http://www.aurasensetherapeutics.com

Information

DUNS: 968721535
# of Employees: 16

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Topically-delivered Mutation-specific Gene Targeting for Epidermolytic Ichthyosis

    Amount: $224,935.00

    DESCRIPTION (provided by applicant): AuraSense Therapeutics (AST), along with Northwestern University, is applying a recently developed technology using oligonucleotide-functionalized nanoparticles (c ...

    SBIRPhase I2014Department of Health and Human Services
  2. Topically-delivered Targeted Gene Suppression of Immune Activation in Psoriasis

    Amount: $149,941.00

    DESCRIPTION (provided by applicant): AuraSense Therapeutics (AST), along with Northwestern University, is applying a recently developed technology using oligonucleotide-functionalized nanoparticles (c ...

    STTRPhase I2014Department of Health and Human Services
  3. Genetically Programmable Spherical Nucleic Acids as Rapidly Adaptable Nanotherapeutics

    Amount: $986,621.00

    AuraSense Therapeutics is developing oligonucleotide-modified gold nanoparticles called Spherical Nucleic Acid (SNA) constructs, which are a powerful new way of regulating cellular gene expression. Au ...

    SBIRPhase II2013Defense Advanced Research Projects Agency Department of Defense
  4. Genetically Programmable Spherical Nucleic Acids as Rapidly Adaptable Nanotherapeutics

    Amount: $149,295.00

    AuraSense Therapeutics is developing oligonucleotide-modified gold nanoparticles called spherical nucleic acid (SNA) constructs, which are a powerful new way of regulating cellular gene expression. Au ...

    SBIRPhase I2012Defense Advanced Research Projects Agency Department of Defense

Agency Micro-sites

US Flag An Official Website of the United States Government